COMMERCIALIZATION SOLUTIONS FOR THE ORTHOPEDIC INDUSTRY
NOVEMBER 2020 | VOLUME 2 | SUBSCRIBE

DePuy Synthes, Stryker, Zimmer Biomet and Smith+Nephew made 40 orthopedic company or technology purchases since 2016. Our latest infographic shares details of these transactions.

This month’s recap rounds up many companies new on our radar, helmed by people who've known the industry for a long time. Geographically, they span the U.S., Canada, France and Turkey.

A burgeoning set of small orthopedic implant companies, including CurvaFix, MedShape and ExsoMed, is developing devices designed to anticipate and suit individual patients’ unique anatomy.

DF(x), a modern design for manufacturability approach, forces orthopedic device companies to develop products aligned with customer needs and business needs.

The ISO 10993-1 changes have re-emphasized the need for orthopedic companies to understand and characterize the materials, processes and risks associated with medical devices.
Did You Miss It?


Notified Body representatives and regulatory consultants provided an update on MDR compliance at OSMA's summer meeting. We review significant changes, legacy devices, economic suppliers and more.

In a perfect world, product development goes smoothly. But we don’t live in a perfect world. Imperfection is why a focus on process improvement to enhance our work product is worth R&D teams pursuing.
Special Focus: Infection Prevention

On November 13, FDA held an inaugural Public Workshop on Orthopedic-Related Infections, specifically the role of medical devices. Surgeon research and commercialization topics covered in BONEZONE in recent years were highlighted during the event. Here, we share relevant articles from our archives.

Post-surgical infection control remains a topic of importance in product development, as surgeons, researchers and device companies seek to reduce complications, readmissions, revisions and cost.

“One of the most important and interesting technological developments in the realm of orthopedic devices is the creation of multifunctional coatings,” says Stuart B. Goodman, M.D., of Stanford.

Javad Parvizi, M.D., a top source on infection prevention, spoke to BONEZONE about why he's dedicated his career to the topic and the state of orthopedic-related infections.

Both companies will make significant investments and share technical capabilities, intellectual property, marketing, clinical data and labor. 

The acquisition includes the STAR® total ankle replacement system, which is accompanied by deep clinical outcomes research, and the comprehensive Silicone, Surface Replacement (SR) and TACTYS® finger joint arthroplasty portfolios.

Copyright © 2020. All Rights Reserved.